The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET
Open accessAbstract
AIMS: Anaemia is a common comorbidity in chronic heart failure (CHF). The predictors of new onset anaemia (NOA) and its long-term prognostic value, particularly in patients treated with beta-blockers, are not known. METHODS AND RESULTS: In COMET, 3029 patients with CHF in NYHA II-IV and EF <35% were randomized to carvedilol or metoprolol tartrate and were followed for an average of 58 months. Plasma haemoglobin (Hb) concentrations were measured at a central laboratory at randomization, at four monthly intervals for the first year and annually thereafter. According to WHO criteria, anaemia was defined when Hb measured <13 g/dL for men and <12 g/dL for women. We considered anaemia to be severe when Hb <11.5 g/dL for men and <10.5 g/dL for women. The baseline mean Hb was 14.2 +/- 1.5 g/dL (n = 2996) and 15.9% of patients had anaemia (males, 16.0%; females, 15.2%). At baseline, severe anaemia was found in 3.3% of patients (males, 3.6%; females, 2.0%). During the study, all-cause mortality (RR 1.47) death or hospitalization (RR 1.28), and heart failure hospitalization (RR 1.43, all P < 0.0001) were higher in anaemic when compared with non-anaemic patients. In patients without anaemia at baseline, at the end of the study, the cumulative frequency of NOA was 28.1% in males and 27.0% in females. NOA increased over time from 14.2% at year 1 to 27.5% at year 5. Predictors of NOA were: higher age, diuretic dose, creatinine (all P < 0.0001), higher serum potassium, lower serum sodium, body mass index, and use of aldosterone antagonists, carvedilol, and digitalis (all P < 0.03). Treatment with carvedilol (vs. metoprolol tartrate) was associated with a 24% increased risk to develop NOA (P = 0.0047), but not severe anaemia (P = 0.18). Patients with a Hb decrease of >3 g/dL (RR 3.37, P < 0.0001) or of 2.0-3.0 g/dL (RR 1.47, P = 0.011) from baseline had an increased subsequent mortality when compared with patients having Hb increases of 0-1.0 g/dL. CONCLUSION: In stable ambulatory CHF patients, development of NOA is frequent and can be predicted by a set of clinical variables. Decreases in Hb over time relate to future increased morbidity and mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ezekowitz, J. A., McAlister, F. A., & Armstrong, P. W. (2003) · Circulation · doi:10.1161/01.cir.0000052622.51963.fc · Cited by 866
Horwich, T. B., Fonarow, G. C., Hamilton, M. A., MacLellan, W. R., & Borenstein, J. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)01854-5 · Cited by 712
The Definition of Anemia in Older Persons
Izaks, G. J. (1999) · JAMA · doi:10.1001/jama.281.18.1714 · Cited by 495
Anemia predicts mortality in severe heart failure
Mozaffarian, D., Nye, R., & Levy, W. C. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00425-x · Cited by 294
Research works printed but not linked: 14
- 2003, Effect of anemia on exercise tolerance in chronic heart failure in men, Am J Cardiol, 91, 888, 10.1016/S0002-9149(03)00030-4 · DOI
- 2005, Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT, Circulation, 112, 1121, 10.1161/CIRCULATIONAHA.104.512988 · DOI · Paper page
- 2004, Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial, Eur Heart J, 25, 1021, 10.1016/j.ehj.2004.04.023 · DOI · Paper page
- 2004, Anemia and its relationship to clinical outcome in heart failure, Circulation, 110, 149, 10.1161/01.CIR.0000134279.79571.73 · DOI · Paper page
- 2004, Prevalence of anemia in patients with chronic heart failure and their clinical characteristics, J Card Fail, 10, S1, 10.1016/j.cardfail.2004.01.003 · DOI
- 2003, Carvedilol Or Metoprolol European Trial Investigators. Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomized controlled trial, Lancet, 362, 7, 10.1016/S0140-6736(03)13800-7 · DOI · Paper page
- 2005, Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anaemia in patients with chronic heart failure, Eur Heart J, 26, 2232, 10.1093/eurheartj/ehi388 · DOI · Paper page
- 2005, Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction, J Am Coll Cardiol, 3, 391
- 2004, Anemia in chronic heart failure: pathogenetic mechanisms, J Card Fail, 10, S5, 10.1016/j.cardfail.2004.01.004 · DOI
- 2000, Lack of angiotensin II-facilitated erythropoiesis causes anemia in angiotensin-converting enzyme-deficient mice, J Clin Invest, 106, 1391, 10.1172/JCI10557 · DOI · Paper page
- 1976, The beta-adrenergic receptor and adenylate cyclase, Biochimi Biophys Acta, 457, 1, 10.1016/0304-4157(76)90012-5 · DOI
- 1966, The effect of central nervous system stimulation on erythropoiesis in rats with chronically implanted electrodes, J Lab Clin MedI, 67, 713
- 1979, Influence of albuterol on erythropoïetin production and erythroid progenitor cell activation, Am J Physiol, 236, H422
- 1984, Adrenergic modulation of erythropoiesis: in vitro studies of colony-forming cells in normal and polycythaemic man, Br J Haematol, 56, 323, 10.1111/j.1365-2141.1984.tb03959.x · DOI
Cited by
Anemia and Mortality in Heart Failure Patients
Groenveld, H. F., Januzzi, J. L., Damman, K., van Wijngaarden, J., Hillege, H. L., van Veldhuisen, D. J., & van der Meer, P. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2008.04.061 · Cited by 764
Treatment of Anemia with Darbepoetin Alfa in Systolic Heart Failure
Swedberg, K., Young, J. B., Anand, I. S., Cheng, S., Desai, A. S., Diaz, R., Maggioni, A. P., McMurray, J. J. V., O'Connor, C., Pfeffer, M. A., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214865 · Cited by 592
Self-citationAnemia and Iron Deficiency in Heart Failure: Current Concepts and Emerging Therapies
Anand, I. S., & Gupta, P. (2018) · Circulation · doi:10.1161/circulationaha.118.030099 · Cited by 584
Prevalence of anaemia in older persons: systematic review
Gaskell, H., Derry, S., Andrew Moore, R., & McQuay, H. J. (2008) · BMC Geriatrics · doi:10.1186/1471-2318-8-1 · Cited by 496
Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives
Jankowska, E. A., von Haehling, S., Anker, S. D., Macdougall, I. C., & Ponikowski, P. (2013) · European Heart Journal · doi:10.1093/eurheartj/ehs224 · Cited by 399
Metadata
- Authors
- Komajda, M., Anker, S. D., Charlesworth, A., Okonko, D., Metra, M., Di Lenarda, A., Remme, W., Moullet, C., Swedberg, K., Cleland, J. G. F., & Poole-Wilson, P. A.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-22
- Volume
- 27
- Issue
- 12
- Pages
- 1440-1446
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2161097402
- Cited by
- 226
- References
- 4
- FWCI
- 10.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. https://app.cochat.ai/papers/10.1093/eurheartj/ehl012
- The paper
- Komajda, M., Anker, S. D., Charlesworth, A., Okonko, D., Metra, M., Di Lenarda, A., Remme, W., Moullet, C., Swedberg, K., Cleland, J. G. F., & Poole-Wilson, P. A. (2006). The impact of new onset anaemia on morbidity and mortality in chronic heart failure: results from COMET. European Heart Journal. https://doi.org/10.1093/eurheartj/ehl012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.